F-FDG PET/CT在恶性疾病再分期及治疗反应评估中的合理应用标准 - Suppr

Appropriate Use Criteria for F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease.

作者信息

Jadvar Hossein, Colletti Patrick M, Delgado-Bolton Roberto, Esposito Giuseppe, Krause Bernd J, Iagaru Andrei H, Nadel Helen, Quinn David I, Rohren Eric, Subramaniam Rathan M, Zukotynski Katherine, Kauffman Julie, Ahuja Sukhjeet, Griffeth Landis

机构信息

Society of Nuclear Medicine and Molecular Imaging (SNMMI)

American College of Nuclear Medicine (ACNM).

出版信息

J Nucl Med. 2017 Dec;58(12):2026-2037. doi: 10.2967/jnumed.117.197988. Epub 2017 Oct 12.

DOI:10.2967/jnumed.117.197988

PMID:29025980

Abstract

摘要

相似文献

Appropriate Use Criteria for F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease.

J Nucl Med. 2017 Dec;58(12):2026-2037. doi: 10.2967/jnumed.117.197988. Epub 2017 Oct 12.

¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.

Eur J Radiol. 2014 Oct;83(10):1925-33. doi: 10.1016/j.ejrad.2014.05.037. Epub 2014 Jun 17.

Whole-body F-fluorodeoxyglucose positron emission tomography-computed tomography (F-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India.

Indian J Med Res. 2018 Mar;147(3):256-262. doi: 10.4103/ijmr.IJMR_1368_16.

Utility of (18)F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours: a single-institutional experience.

Nucl Med Commun. 2013 Mar;34(3):211-9. doi: 10.1097/MNM.0b013e32835bc4c4.

The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.

Nucl Med Commun. 2017 Apr;38(4):319-324. doi: 10.1097/MNM.0000000000000652.

Standardization and quantification in FDG-PET/CT imaging for staging and restaging of malignant disease.

PET Clin. 2014 Apr;9(2):117-27. doi: 10.1016/j.cpet.2013.10.003. Epub 2013 Dec 5.

Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.

Eur J Radiol. 2018 Oct;107:158-165. doi: 10.1016/j.ejrad.2018.09.003. Epub 2018 Sep 5.

Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.

Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):404-13. doi: 10.1007/s00259-015-3184-5. Epub 2015 Sep 18.

Value of 18F-FDG PET/CT imaging in the staging, restaging, monitoring of response to therapy and surveillance of uterine leiomyosarcomas.

Nucl Med Commun. 2018 Jul;39(7):652-658. doi: 10.1097/MNM.0000000000000848.

Clinical and prognostic value of 18F-FDG-PET/CT in restaging of pancreatic cancer.

Nucl Med Commun. 2018 Aug;39(8):741-746. doi: 10.1097/MNM.0000000000000862.

引用本文的文献

Added value of dual-phase Tc-HYNIC-FAPI-04 SPECT/CT in postoperative follow-up of colorectal cancer.

Front Oncol. 2025 Jun 16;15:1500273. doi: 10.3389/fonc.2025.1500273. eCollection 2025.

FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?

Ann Nucl Med. 2025 May;39(5):407-423. doi: 10.1007/s12149-025-02022-x. Epub 2025 Mar 11.

A Systematic Literature Review of Modelling Approaches to Evaluate the Cost Effectiveness of PET/CT for Therapy Response Monitoring in Oncology.

Pharmacoeconomics. 2025 Feb;43(2):133-151. doi: 10.1007/s40273-024-01447-y. Epub 2024 Nov 3.

F-Fluorodeoxyglucose Uptake in Bilateral Diaphragmatic Crura: A Relatively Uncommon Benign Variant Noted in a Treated Case of Extraosseous Paraspinal Ewing's Sarcoma.

World J Nucl Med. 2024 Feb 6;23(1):54-56. doi: 10.1055/s-0044-1779284. eCollection 2024 Mar.

Organ-specific accuracy of [F]FDG-PET/CT in identifying immune-related adverse events in patients with high-risk melanoma treated with adjuvant immune checkpoint inhibitor.

Jpn J Radiol. 2024 Jul;42(7):753-764. doi: 10.1007/s11604-024-01554-y. Epub 2024 Mar 20.

Diagnostic Performance of [F]F-FDG Positron Emission Tomography (PET) in Non-Ophthalmic Malignant Melanoma: A Systematic Review and Meta-Analysis of More Than 10,000 Melanoma Patients.

Cancers (Basel). 2024 Jan 2;16(1):215. doi: 10.3390/cancers16010215.

Metabolic Tumor Volume from F-FDG PET/CT in Combination with Radiologic Measurements to Predict Long-Term Survival Following Transplantation for Colorectal Liver Metastases.

Cancers (Basel). 2023 Dec 19;16(1):19. doi: 10.3390/cancers16010019.

PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group.

Lancet Oncol. 2024 Jan;25(1):e29-e41. doi: 10.1016/S1470-2045(23)00525-9.

Metabolic tumor volume predicts long-term survival after transplantation for unresectable colorectal liver metastases: 15 years of experience from the SECA study.

Ann Nucl Med. 2022 Dec;36(12):1073-1081. doi: 10.1007/s12149-022-01796-8. Epub 2022 Oct 14.

The Release of a Highly Cytotoxic Paullone Bearing a TEMPO Free Radical from the HSA Hydrogel: An EPR Spectroscopic Characterization.

Pharmaceutics. 2022 May 30;14(6):1174. doi: 10.3390/pharmaceutics14061174.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Appropriate Use Criteria for F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献